Antibody Against Sclerostin Protein Improves Bone Health in Mice with XLH, Study Finds
Treatment with an antibody targeting a protein called sclerostin improved bone mass and strength in a mouse model of X-linked hypophosphatemia (XLH), a study shows. The study, “Sclerostin antibody treatment increases bone mass and normalizes circulating phosphate levels in growing Hyp mice,” was published in the Journal…